GOLDMAN SACHS GROUP INC - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 38 filers reported holding NRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$16,000
+14.3%
21,619
-4.0%
0.00%
Q2 2022$14,000
-73.1%
22,512
+5.7%
0.00%
Q1 2022$52,000
-44.7%
21,294
+8.5%
0.00%
Q4 2021$94,00019,6190.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Texas Capital Bank Wealth Management Services Inc 63,290$41,7140.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 230,700$152,0540.00%
Virtu Financial LLC 46,210$300.00%
United Asset Strategies, Inc. 18,300$12,0620.00%
HBK Sorce Advisory LLC 29,230$19,2660.00%
UBS Group AG 18,611$12,2650.00%
NewEdge Advisors, LLC 2,125$1,4010.00%
OSAIC HOLDINGS, INC. 27,225$17,9330.00%
BANK OF AMERICA CORP /DE/ 30,000$19,7700.00%
WELLS FARGO & COMPANY/MN 5,309$3,5000.00%
View complete list of NRX PHARMACEUTICALS INC shareholders